Tamsulosin HCL MR + Dutasteride Tablets Manufacturer in India & Exporter

Tamsulosin HCL MR + Dutasteride Tablets

Categories : Nephrology & Urology

Product Packaging : 10 / 30 tablets

Product Composition : 0.4 mg + 0.5 mg

Tamsulosin HCL MR + Dutasteride Tablets are a clinically proven combination therapy formulated for the effective management of benign prostatic hyperplasia (BPH) and associated lower urinary tract symptoms (LUTS) in men. This dual-action formulation provides both rapid symptomatic relief and long-term disease control:

Tamsulosin HCL (Modified Release) is a selective alpha-1A adrenergic blocker that relaxes smooth muscles in the prostate and bladder neck, improving urine flow
Dutasteride inhibits 5-alpha reductase, reducing dihydrotestosterone (DHT) levels and gradually shrinking prostate size

Genliva Wellness LLP is a trusted Tamsulosin HCL MR + Dutasteride Tablets manufacturer in India, delivering high-quality formulations through WHO-GMP and ISO-certified pharmaceutical manufacturing facilities. As a reliable Tamsulosin Dutasteride Tablets exporter and contract manufacturer, the company ensures consistent efficacy, regulatory compliance, and global-quality standards.

With strong expertise in pharmaceutical contract manufacturing, third-party production, and international export, Genliva Wellness LLP supplies this combination to Africa, Southeast Asia, CIS countries, Middle East, and Latin America, supporting urology specialists, hospitals, and global distributors.

Send Message

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Tamsulosin HCL (Modified Release) is a selective alpha-1A adrenergic blocker that relaxes smooth muscles in the prostate and bladder neck, improving urine flow
Dutasteride inhibits 5-alpha reductase, reducing dihydrotestosterone (DHT) levels and gradually shrinking prostate size

Leading Tamsulosin HCL MR + Dutasteride Tablets manufacturer in India with GMP certification
Reliable Tamsulosin Dutasteride Tablets exporter for global pharmaceutical markets
Specialized Tamsulosin Dutasteride Tablets contract manufacturer for third-party production
Modified-release formulation for controlled drug release and sustained action
Dual-action therapy for immediate symptom relief and long-term prostate size reduction
Tamsulosin MR ensures improved urinary flow and reduced LUTS symptoms
Dutasteride provides DHT suppression and disease progression control
Available in standard combinations such as Tamsulosin 0.4 mg MR + Dutasteride 0.5 mg tablets
Manufactured using high-quality APIs under strict quality assurance protocols
Suitable for bulk supply, institutional procurement, and chronic therapy markets
Offered with custom packaging, private labeling, and export documentation support
Backed by Genliva’s reputation as a global pharmaceutical exporter from India

Tamsulosin HCL MR + Dutasteride Tablets are widely used in urology for:

Treatment of benign prostatic hyperplasia (BPH)
Management of lower urinary tract symptoms (LUTS)
Improvement of urinary flow and bladder emptying
Relief from symptoms such as:
- Frequent urination
- Weak urine stream
- Hesitancy and incomplete emptying
- Nocturia
Reduction in prostate size over time
Prevention of acute urinary retention (AUR)
Decreasing the need for surgical intervention

Modified-release tablet ensures controlled and sustained drug delivery
Provides once-daily dosing with improved patient compliance
Reduces fluctuations in plasma drug levels for better tolerability
Combination therapy minimizes the need for multiple medications
Stable formulation suitable for long shelf life and export conditions
Available in blister packs and bulk export packaging formats
Ideal for private label pharmaceutical brands and international distributors